Results 191 to 200 of about 21,860 (253)

Programmed cell death inhibitors: a new hope for cancer therapy? [PDF]

World J Surg Oncol
Zhong Y, Zhang Y, Cheng L, Chen Q, Zhang G, Xuan Z.   +5 more
europepmc   +1 more source

Peroxiredoxin 1 as a novel pyroptosis inducer in colorectal cancer: Insights and future directions. [PDF]

World J Gastroenterol
Chen ZK, Zhao JW, Meng WY, Wang YG.
europepmc   +1 more source

Letter to Editor Regarding: "Serum Pyroptosis-Related Cytokines as Biomarkers for Diagnostic Assessment and Risk Stratification of Ocular Graft-Versus-Host Disease: A Case-Control Study." [Response to Letter]. [PDF]

J Inflamm Res
Lou J, Xu Y, Zhuang X, Zhao Y, Pan H, Chen Y, Zhang X, Lu P.   +7 more
europepmc   +1 more source

The molecular mechanisms of pyroptosis and its implications in tumor immunotherapy. [PDF]

Mol Cancer
Chen G, Zhang Z, Chong W, Qiu G, Li Z, Yang S, Pan X, Ma T, Lian G, Wang X, Li L, Tian F, Jing C.   +12 more
europepmc   +1 more source

When Infection Meets Inflammation: <i>Listeria monocytogenes</i> and Host Signaling Pathways. [PDF]

Biology (Basel)
Jia Y, Yang K, Guo R, Ding K, Wang S, Chen S.   +5 more
europepmc   +1 more source

PANoptosis: a new perspective for targeting programmed cell death after spinal cord injury. [PDF]

Front Immunol
Qian Q, Shi L, Xie J, Zhao X, Meng X.
europepmc   +1 more source

Discovery of spectosis supports the key role of caspase-8 in determining the type of cell death in mature erythrocytes and erythrocyte death-driven immunogenicity. [PDF]

Cell Death Discov
Tkachenko A.
europepmc   +1 more source

Pyroptosis-driven immune dysregulation in COPD: molecular mechanisms and therapeutic implications. [PDF]

Front Immunol
Ni FX, Wang HX, Hu J, Chen PS, Huang HJ, Chen HH, Huang DH, Jiang ZB.   +7 more
europepmc   +1 more source

RBM47-Induced Gasdermin A/GSDMA Mediates Mesenchymal-Epithelial Transition and Pyroptosis of Colorectal Cancer Cells. [PDF]

Cancers (Basel)
Du Y, Rokavec M, Hermeking H.
europepmc   +1 more source